Scholarly publishing renders a great service
to science, research and academic literature. The industry is largely dominated
by subscription-based publishing which has existed for as long as the scholarly
journals publishing it (Paul Peters, 2007). Academic journals and the quality
of the research published in them are judged by their impact factor, a measure
of the number of citations to articles published in the journals.
Bentham Science is a rapidly growing
scholarly journal publisher and has been serving the academia and libraries for
the last 25 years. They publish 122 subscription based journals, while their
flagship products include 32 journals with impact factors. Current Medicinal
Chemistry has an impact factor of 4.07 and is considered to be one of the most
popular peer-reviewed journals in its respective field. It publishes the latest
research, new developments in the field of medicinal chemistry and drug. This
is one of the most highly recommended journals in the field of medicinal
chemistry.
Another name in the list of high impact
factor journals from Bentham Science Publishers’ is Current Cancer Drug Targets. The impact
factor for this journal is 4.00. aims to cover all the latest and outstanding
developments on the medicinal chemistry, pharmacology, molecular biology,
genomics and biochemistry of contemporary molecular drug targets involved in
cancer, e.g. disease specific proteins, receptors, enzymes and genes. It
publishes original research articles, latest reviews and clinical studies.
Current Molecular Medicine (Impact Factor: 4.197) covers the recent
developments in the fundamental molecular mechanisms of disease pathogenesis,
and the development of molecular-diagnosis and/or novel approaches to rational
treatment.
For a complete list of Bentham Science Publishers’ High Impact Factor
Journals, kindly log on to http://benthamscience.com/IFTitles.htm and https://www.facebook.com/benthamimpactfactorjournals?ref=hl.
0 comments:
Post a Comment